We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00319813
First Posted: April 27, 2006
Last Update Posted: April 16, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Boehringer Ingelheim
April 20, 2006
April 27, 2006
April 16, 2008
Not Provided
Not Provided
  • To optimise the diagnosis and treatment of COPD via a quality assurance project
  • Increase the knowledge and use of diagnostic tools and treatment amongst PCPs
  • To focus on implementation of national guidelines for diagnosis and treatment of COPD
Not Provided
Complete list of historical versions of study NCT00319813 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment
General Practice Quality Assurance Project. COPD Diagnosis and Treatment
A Cross sectional observational Quality Assurance Project in General Practice to COPD Diagnosis and Treatment
Not Provided
Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
Pulmonary Disease, Chronic Obstructive
Behavioral: Education
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
8000
September 2007
Not Provided

Inclusion Criteria:

  • COPD patients over 35 years of age
  • More than two annual renewals with the following group of inhalation preparations: Anticholinergic, beta-2 antagonists, steroids or a combination of these

Exclusion Criteria:

  • Asthma
Sexes Eligible for Study: All
35 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
Denmark
 
NCT00319813
205.376
Not Provided
Not Provided
Not Provided
Not Provided
Boehringer Ingelheim
Not Provided
Study Chair: Boehringer Ingelheim Study Coordinator B.I. Denmark A/S
Boehringer Ingelheim
April 2008